prospective multicenter

Related by string. Prospective Multicenter * PROSPECTIVE . prospectives . pro spective . Prospective : Identify prospective partners . • Identify prospective . prospective groom . prospective jurors / Multicenter : multicenter Phase II . multicenter randomized double . Multicenter Randomized Double * prospective multicenter study . prospective multicenter randomized *

Related by context. Frequent words. (Click for all words.) 76 multicentre 76 multicenter clinical 75 prospective randomized 75 randomized Phase III 73 multicenter 72 multicenter randomized double 70 randomized controlled 70 randomized controlled clinical 70 randomized clinical 67 multicenter study 67 blind randomized placebo 67 randomized 67 Phase 1b clinical 67 blind randomized 66 randomized placebo controlled 66 phase IIb 66 phase IIa 66 RESOLUTE 65 Phase 2b study 65 placebo controlled 65 dose escalation trial 65 substudy 64 Phase 2a clinical 64 Phase 2b clinical 64 dose escalation study 64 Phase III pivotal 64 noninferiority 64 label dose escalation 63 Randomized 63 blinded placebo controlled 63 Phase Ib 63 Phase 1b 63 dabigatran etexilate 63 dose escalation 63 confirmatory Phase III 62 Phase IIa trial 62 Phase 2a trial 62 randomized double 62 ATTRACT 62 CYPHER ® Stent 61 pivotal Phase III 61 EORTC 61 randomized controlled trial 61 Phase 1b trial 61 Phase IIa clinical 61 Phase IIb 61 SPIRIT III 61 Phase IIb clinical 61 unblinded 61 Phase 2b trial 61 randomized #:# 61 TAXUS stent 61 double blind placebo 61 subgroup analyzes 60 Stent System 60 composite endpoint 60 phase 2a 60 randomized Phase 60 echocardiographic 60 REALIZE 60 CYPHER R Stent 60 Phase IIa 60 Coronary Stent 59 retrospective cohort study 59 clinical trial 59 Phase III clinical 59 Phase IIb trial 59 Myocardial Infarction 59 ACTEMRA 59 decitabine 59 elagolix 59 Phase 2b 59 tocilizumab 59 Phase Ia 59 CA4P 58 TELCYTA 58 azacitidine 58 TORISEL 58 tesmilifene 58 CoFactor 58 placebo controlled trials 58 carotid stenting 58 relapsing remitting multiple sclerosis 58 dose cohorts 58 Taxotere ® 58 plus prednisone 58 FOLFIRI 58 Phase III 58 Phase 2a 58 Stenting 58 blind placebo controlled 58 metastatic renal cell carcinoma 57 invasive bladder 57 evaluable patients 57 bronchial thermoplasty 57 Phase 1a 57 PROMACTA 57 ZYBRESTAT 57 non inferiority 57 biologic therapy 57 angiographic

Back to home page